Krzysztof Tomasiewicz

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals

Julia Dietz, S. Süsser, Johannes Vermehren et al. · Gastroenterology · 2017 · 147 citations

Viral Hepatitis, Direct-acting Antivirals, Antiviral Therapy +8

The present and future disease burden of hepatitis <scp>C</scp> virus (<scp>HCV</scp>) infections with today's treatment paradigm – volume 2

Angelos Hatzakis, Vladimir Chulanov, Adrián Gadano et al. · Journal of Viral Hepatitis · 2015 · 124 citations · Full text

Viremic Population, Autoimmune Liver Disease, Viral Hepatitis +19

Real‐world effectiveness and safety of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C: AMBER study

Robert Flisiak, Ewa Janczewska, Marta Wawrzynowicz‐Syczewska et al. · Alimentary Pharmacology & Therapeutics · 2016 · 99 citations · Full text

Historical epidemiology of hepatitis C virus (<scp>HCV</scp>) in select countries – volume 2

V A Saraswat, Suzanne Norris, Robert J. de Knegt et al. · Journal of Viral Hepatitis · 2015 · 93 citations · Full text